Studies on the genetic susceptibility for NPC have identified certain genetic variations of the HLA genes and TERT/CLPTM1L genes to be associated with a predisposition to NPC (WHO type III) (Bei et al. 2016; Bei et al. 2010; Liu et al. 2017). This evidence concerns the gene TERT and nasopharyngeal carcinoma.